Revenue: The sum of all revenue fields included for a company's operating activities.
Aytu BioPharma Inc. (AYTU) had Revenue of $15.13M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
|
Revenue |
$15.13M |
$-19.82M |
|
$4.88M |
|
$10.25M |
|
$22.76M |
|
$-7.62M |
|
$-11.82M |
|
$-19.44M |
|
$-19.44M |
|
$-19.88M |
|
$-19.88M |
|
$-19.82M |
|
$-19.88M |
|
$-7.62M |
|
$-6.30M |
|
6.28M |
|
6.28M |
|
$-3.18 |
|
$-1.96 |
|
| Balance Sheet Financials | |
$79.18M |
|
$0.53M |
|
$45.00M |
|
$124.18M |
|
$63.06M |
|
$10.89M |
|
$42.15M |
|
$105.21M |
|
$18.97M |
|
$-23.23M |
|
$18.97M |
|
8.98M |
|
| Cash Flow Statement Financials | |
$-1.94M |
|
$-2.56M |
|
$15.44M |
|
$20.01M |
|
$30.95M |
|
$10.95M |
|
$0.58M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
0.36 |
|
1.15 |
|
67.75% |
|
-50.37% |
|
-50.37% |
|
-- |
|
-128.46% |
|
-130.94% |
|
$-1.50M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.43 |
|
0.49 |
|
185.26 |
|
-104.82% |
|
85.56% |
|
-16.01% |
|
-66.58% |
|
$2.11 |
|
$-0.24 |
|
$-0.31 |
|